Roger Jeffs, Director at Axsome Therapeutics, Inc. (AXSM), sold 572 shares at $246.18 ($142K) on 2026-06-10, disclosed to the SEC on 2026-06-11.
Scheduled sale ($142k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $246.18 | 286 | $70K | 49.7% |
| 2 | $249.12 | 286 | $71K | 50.3% |
| Total | $247.65 avg | 572 | $142K | 100% |
| Filing → |
| LQDA | SELL | 2026-05-26 | $4.6M | — | Filing → |
| LQDA | SELL | 2026-05-20 | $4.4M | — | Filing → |
| LQDA | SELL | 2026-05-15 | $4.3M | — | Filing → |